# methyldopa

### notes
+ prescription under medical supervision
### therapeutic action

+ centrally acting antihypertensive

### indications
+ hypertension in pregnancy

### presentation
+ 250 mg tablet

### dosage
+ initially 500 to 750 mg/day in 2 to 3 divided doses for 2 days, then increase gradually if necessary by 250 mg every 2 to 3 days, until the optimal dose is reached, usually 1.5 g/day. do not exceed 3 g/day.

### duration
+ according to clinical response. do not stop treatment abruptly; reduce doses gradually.

### contra-indications, adverse effects, precautions
+ do not administer to patients with active liver disease, history of drug-related liver disease, severe depression.
+ administer with caution to patients with hepatic impairment, and reduce doses in patients with renal impairment.
+ may cause:
    - orthostatic hypotension, drowsiness, headache, gastrointestinal disturbances, dry mouth;
    - rarely: haematological, hepatic, psychical disorders; allergic reactions.
+ stop treatment if haemolytic anaemia or jaundice appear during treatment.
+ in the event of unexplained fever during treatment, check blood count and transaminases for possible hepatitis due to methyldopa.
+ monitor combination with lithium (risk of lithium overdose), antidepressants (enhanced hypotensive effect), cns depressants (increased sedation).
+ *pregnancy*: no contra-indication
+ *breast-feeding*: no contra-indication

### remarks
+ storage: below 25Â°c